Fabino Life Sciences Limited

Equities

543444

INE0DRT01018

Pharmaceuticals

Market Closed - Bombay S.E. 11:00:55 26/06/2024 BST 5-day change 1st Jan Change
26.05 INR -4.40% Intraday chart for Fabino Life Sciences Limited -4.40% -5.27%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Fabino Life Sciences Changes Name to Fabino Enterprises MT
Fabino Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Fabino Life Sciences Limited Approves Executive Changes CI
Fabino Life Sciences Limited Approves Change in Designation of Aditya Mahavir Jain from Non?Executive Director to Managing Director CI
Fabino Life Sciences Managing Director Steps Down MT
Fabino Life Sciences Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Fabino Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Fabino Life Sciences Limited Announces Incorporation of Wholly Owned Subsidiary CI
Fabino Life Sciences Limited Announces Change in Registered Office Address CI
Fabino Life Sciences Limited Announces Executive Changes CI
Fabino Life Sciences Limited Announces Resignation of Aslam Mohammad as Company Secretary and Compliance Officer CI
774,000 Equity Shares of Fabino Life Sciences Limited are subject to a Lock-Up Agreement Ending on 2-FEB-2023. CI
Fabino Life Sciences Turns to Profit in Fiscal H1; Shares Jump 6% MT
Fabino Life Sciences Limited Reports Earnings Results for the Half Year Ended September 30, 2022 CI
Fabino Life Sciences Limited Appoints Aslam Mohamrnad as Company Secretary and Compliance Officer CI
Fabino Life Sciences Limited Announces Resignation of Jeel Poshiya as Company Secretary and Compliance Officer, Effective August 04, 2022 CI
Fabino Life Sciences Limited Announces Shifting of Registered Office CI
Fabino Life Sciences Limited Appoints Sumit Malik as Additional Director (Non-Executive) CI
Fabino Life Sciences Limited has completed an IPO in the amount of INR 32.4 million. CI
Fabino Life Sciences Limited has filed an IPO. CI
Chart Fabino Life Sciences Limited
More charts
Fabino Enterprises Limited, formerly Fabino Life Sciences Ltd, is an India-based pharmaceutical company. It offers a range of allopathic and herbal products. Its product categories include allopathic products, Covid-19 products, food supplements, herbal products, multi-vitamin products, and veterinary products. Its allopathic products include AMOXRAG-625, Astrid Syrup, Aurceta AM, Aurifox OZ, Aurirug 200, Aurirug O, Aurnim Plus, Aurstin 250, Ceporag O, Doref M, Dr-DSR, F Plexus A, and Fabpara. Its Covid-19 products include disposable face shield, fabclean hand sanitizer, mask and personal protective equipment (PPE). Its herbal products include Aurcis-Forte, Aurzyme-Syrup, Ayush Kadha, Coptec-syrup, DStoren-Syrup, Ecstasy Tilla Oil, Fablactin, Giloy Power, Keepshine Hair Oil, Onion Hair Oil, Pain-Go, Power Malt, Regaliv-ds, Sandy Forte and M-Sharp-Brain-tonic. Its multi-vitamin products include Aur D3 Capsules, Coptec Capsules, FABZYM CAPSULE, Oshnine Plus, and Rigovit Softgel Capsules.
More about the company
  1. Stock Market
  2. Equities
  3. 543444 Stock
  4. News Fabino Life Sciences Limited
  5. Fabino Life Sciences Changes Name to Fabino Enterprises